Whether this injection is suitable for you is discussed during your consultation
In 2021, a higher dose (2.4 mg) once-weekly formulation of semaglutide (branded Wegovy), was approved for obesity
At the same time, FDA actions in 2026 to restrict non-approved compounded GLP-1 APIs and clarify lawful compounding requirements concentrate demand back toward approved products and compliant supply chains, creating space for contract manufacturing, serialization and cold-chain services, and regulated follow-on competition focused on availability and cost of goods rather than grey-market substitutes
Naming the blood glucose-lowering substance 'pancreine'
If your current provider is unfamiliar with or opposed to this approach, functional medicine practitioners and integrative rheumatologists are more likely to have experience with GLP-1 microdosing for autoimmune applications
Cost For a more affordable option, L-glutathione is the best option